2'-deoxy-2'-methylenecytidine and Carcinoma, Non-Small Cell Lung

2'-deoxy-2'-methylenecytidine has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Tsukagoshi, S	1
Brindley, CJ; Devlin, AJ; Friberg, LE; Karlsson, MO	1
Fukuoka, M; Matsui, K	1

Reviews

2 review(s) available for 2'-deoxy-2'-methylenecytidine and Carcinoma, Non-Small Cell Lung

Article	Year
[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues]. Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7 Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation	1997
[New antitumor antimetabolites--gemcitabine and DMDC]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:13 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male	1992

Article

Year

[Recent development of antitumor antimetabolites in Japan--cytosine arabinoside analogues].

Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:7

Topics: Animals; Antimetabolites, Antineoplastic; Arabinonucleotides; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Cytidine Monophosphate; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation

1997

[New antitumor antimetabolites--gemcitabine and DMDC].

Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:13

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Lung Neoplasms; Male

1992

Other Studies

1 other study(ies) available for 2'-deoxy-2'-methylenecytidine and Carcinoma, Non-Small Cell Lung

Article	Year
Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC). European journal of clinical pharmacology, 2000, Volume: 56, Issue:8 Topics: Antineoplastic Agents; Blood Platelets; Body Fluid Compartments; Carcinoma, Non-Small-Cell Lung; Cell Survival; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Hematologic Diseases; Humans; Leukocyte Count; Leukocytes; Lung Neoplasms; Models, Biological; Neutropenia; Neutrophils; Platelet Count	2000

Article

Year

Models of schedule dependent haematological toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC).

European journal of clinical pharmacology, 2000, Volume: 56, Issue:8

Topics: Antineoplastic Agents; Blood Platelets; Body Fluid Compartments; Carcinoma, Non-Small-Cell Lung; Cell Survival; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Hematologic Diseases; Humans; Leukocyte Count; Leukocytes; Lung Neoplasms; Models, Biological; Neutropenia; Neutrophils; Platelet Count

2000